Biometrische Grundlagen der Medizin

Diehl V, et al. Interim analysis of the HD9 study of the German Hodgkin study group (GHSG) — BEACOPP is more effective than COPP-ABVD in advanced stage Hodgkin’s disease. JASH 1997;90:Suppl 1:339a/1512–31. Duhmke E, Diehl V, Loeffler M, et al. Randomized trial with early-stage Hodgkin’s disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone. Int J Radiat Oncol Biol Phys 1996;36:305–10. Early Breast Cancer Trialists’ Collaborative Group: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med 1988;319:1681–92. Early Breast Cancer Trialists’ Collaborative Group: Systemic treatment of early breast cencer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1–15. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 1993;328:1002–6. Gross R, Loeffler M. Prinzipien der Medizin. Eine Ubersicht ihrer Grundlagen und Methoden. Berlin-Heidelberg-New York: Springer, 1997. Hasenclever D, Loeffler M, Dichl V. Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin’s disease. German Hodgkin’s Lymphoma Study Group. Ann Oncol 1996;7:Suppl 4:95–8. Kahnemann D, Slovie P, Tversky A, eds. Ludgement under uncertainty: heuristics and biases. Cambridge/Mass.: Cambridge Univ. Press, 1982. Sacks H, Chalmers TC, Smith H Jr. Randomized versus historical controls for clinical trials. Am J Med 1982;72:233–40.